Mexico's IMSS institute invests US$444m in medical equipment
This article was originally published in Clinica
Executive Summary
Mexico's IMSS institute, the country’s main healthcare provider for private sector workers and their families, is to invest Peso5.6bn (US$444m) in medical equipment during 2010. The investment is part of a Peso6.2bn infrastructure modernisation programme. The IMSS hospitals' busiest A&E services will specifically get Peso1.2bn, according to a statement.
You may also be interested in...
Biogen Sees Improving Momentum In Slow Leqembi Launch
Sales of the company’s new drugs have a lot of growing to do to make up for older products’ declines, but Biogen highlighted signs of strength for new launches in its Q1 report.
Vivalink Partners With Rett Syndrome Research Trust To Accelerate Research In Rare Disease
Vivalink will provide ECG wearable technology to monitor patients in RSRT’s Vibrant study, which is aimed at assessing autonomic dysfunction in children with Rett syndrome.
Cidara Offloads Rezzayo, Will Focus On Universal Flu Preventative
Cidara conferred global rights to its novel antifungal to marketing partner, Mundipharma, while reacquiring a flu prophylaxis it licensed to J&J in 2021 and gaining $240m in new funding to back development.